Mei‐jou Chen - Gynecology

Author Information

Mei-Jou Chen is affiliated with the Department of Obstetrics and Gynecology at National Taiwan University Hospital in Taipei, Taiwan. She also holds the position of Livia Shang Yu Wan Chair Professor of Obstetrics and Gynecology at the College of Medicine, National Taiwan University, Taipei, Taiwan.

Research Contributions

Mei-Jou Chen has made significant contributions to the field of gynecology, particularly in areas related to fertility preservation, polycystic ovary syndrome (PCOS), and ovarian stimulation protocols. Her research includes exploring the effects of metformin on fertility preservation during chemotherapy, the impact of obesity on ovarian function, and novel protocols to manage ovarian hyperstimulation syndrome. Her work is widely recognized and cited, reflecting her influence and expertise in the field.

Aliases

Mei-Jou Chen is also known by the alias Mei-jou Chen.

Publication and Citation Metrics

Metrics	Value
Citation Count	2164
h-index	28
Paper Count	85

Publications:

Metformin: a novel promising option for fertility preservation during cyclophosphamide-based chemotherapy

DOI: 10.1093/molehr/gaaa084

Year: 2021

Obesity alters ovarian folliculogenesis through disrupted angiogenesis from increased IL-10 production

DOI: 10.1016/j.molmet.2021.101189

Year: 2021

Metformin: a novel promising option for fertility preservation during cyclophosphamide-based chemotherapy.

DOI: 10.1093/molehr/gaaa084

Year: 2021

Obesity Exacerbates Irritable Bowel Syndrome-Related Sleep and Psychiatric Disorders in Women With Polycystic Ovary Syndrome

DOI: 10.3389/fendo.2021.779456

Year: 2021

Metabolic Syndrome in Polycystic Ovary Syndrome

DOI: 10.1142/s2661318221500158

Year: 2021

Progestin primed ovarian stimulation using corifollitropin alfa in PCOS women effectively prevents LH surge and reduces injection burden compared to GnRH antagonist protocol

DOI: 10.1038/s41598-021-02227-w

Year: 2021

Changes in peripheral mitochondrial DNA copy number in metformin-treated women with polycystic ovary syndrome: a longitudinal study

DOI: 10.1186/s12958-020-00629-5

Year: 2020

A novel GnRH-antagonist protocol by switching to medroxyprogesterone when patients being at risk of ovarian hyperstimulation syndrome during ovarian stimulation.

DOI: 10.1016/j.jfma.2019.12.006

Year: 2020

Lower rate of early pregnancy loss in patients experiencing early-onset low LH in GnRH antagonist cycles supplemented with menotropin.

DOI: 10.1016/j.jfma.2018.01.012

Year: 2019

Metformin: a novel option of fertility preservation during cyclophosphamide-containing chemotherapy

DOI: 10.1016/j.fertnstert.2019.07.341

Year: 2019

How is Cord Blood Collected?

Why are Pelvic Floor Exercises Important?

What role do biologics play in gynecology?

What are common symptoms of gynecological problems?

Is Hormonal Imbalance Common During Menopause?

How Effective is Pelvic Venography?

What are the Penalties for HIPAA Violations?

What Alternatives Are Available?

What is the Parietal Peritoneum?

Why is Dosage Control Important in Gynecology?

Partnered Content Networks

Relevant Topics